Group Leader - Biology in Sutton - The Institute of Cancer Research

Location:

Sutton

Position:

Cancer Therapeutics

Salary Details:

Not Specified

Contract:

Permanent

Contract Length:

Not Specified

Advertising End Date:

05 Jul 2026

Home
Vacancies
Group Leader - Biology

Key Information

Salary: Salary from £71,096 per annum. Commencement on the salary range is subject to comparable skills and experience. Future progression is based on annual performance review.

Duration of Contract: Permanent

Hours per week: 35 hours per week (Full Time)

Closing Date: 5th of July

For Career Faculty appointments the post-holder’s salary will be determined by the CEO of the ICR.

This role is eligible for ICR Sponsorship. If this is your first visa in the UK, support will be provided for costs associated with Visa application. If you are considering relocating to the UK, further information can be found here.

Job Details

Under the guidance of Professor Sebastian Nijman, we are seeking to recruit a Group Leader to lead an independent research group that contributes directly to target identification and small molecule drug discovery; lead and participate in multidisciplinary drug discovery research teams.

Experience

Proven ability to contribute to drug discovery activities
Proven scientific productivity and leadership by means of high-profile publication and/or patents
Skills in co-ordinating, planning and executing novel (target) biology studies to a standard of international excellence
Demonstrated expertise in building and running biological assays for use in drug discovery test cascades
Ability to rapidly assimilate relevant information, identify new research opportunities, and clearly communicate recommendations
Evidence of a strategic and inclusive approach to decision making and performance management
Excellent track record of cross-disciplinary collaboration
Effective stakeholder engagement through strong relationship building and communication skills
Evidence of the ability to lead and manage research staff, with a focus on performance and development

Division of Cancer Therapeutics

The Division of Cancer Therapeutics has an unrivalled track record at discovering novel cancer treatments for the personalised treatment of cancer. Within the Division, the Centre for Cancer Drug Discovery (CCDD) is a multidisciplinary 'bench to bedside' centre, comprising 160 staff dedicated to the discovery and development of novel therapeutics for the treatment of cancer. We are one of the largest academic cancer drug discovery groups in the world and, together with our collaborators, have discovered 21 preclinical development candidates, 13 of which have been progressed to clinical evaluation, many with our partners in the ICR/Royal Marsden Drug Development Unit. Our drug abiraterone (Zytiga) has been approved in the US, Canada and Europe for late-stage prostate cancer whereas the pan-AKT inhibitor capiversitib is on the market for breast cancer since 2023.

The CCDD’s mission is to develop “first in class” personalised medicines for patient benefit. We implement innovative drug discovery technologies, discover novel mechanism-based drugs, and develop these as rapidly as possible from the laboratory through to hypothesis-testing early clinical trials. We publish our work extensively and have a large network of collaborations with academia, biotechnology companies, and the pharmaceutical industry. Our teams are dedicated to the discovery of small molecule drug candidates, and to the development of high-quality chemical probes to enable new cancer biology research. The Division of Cancer Therapeutics is based in state-of-the art laboratories in the Centre for Cancer Drug Discovery building, opened in 2020 on the ICR Sutton campus.

About The Institute of Cancer Research

We are one of the world’s oldest and most influential cancer research institutes with an outstanding record of achievement dating back more than 100 years. We are world leaders in identifying cancer genes, discovering cancer drugs and developing precision radiotherapy. Together with our hospital partner The Royal Marsden, we are consistently rated in the top four centres for cancer research and treatment worldwide.

As well as being a world-class institute, we are a college of the University of London. We are consistently in the top performing universities in the league table of university research quality compiled from the Research Excellence Framework (REF 2014 & 2021).

About The Institute of Cancer Research

Why work for us?

As a member of staff, you'll have exclusive access to a range of staff benefits.

The ICR is committed to supporting overseas applicants applying for roles, please click here to find out further information.

The Institute of Cancer Research, London, is one of the world's most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. Further information about working at the ICR can be found here.

At the Institute of Cancer Research, we champion diversity as we believe it fuels innovation and drives impactful research. We welcome applicants from all walks of life, valuing diverse perspectives that enrich our work.

Don't let a checklist of qualifications hold you back – if you're passionate about the role, we want to hear from you. Your unique experiences and backgrounds contribute to the richness of our team. We are committed to being an equal opportunity for all, regardless of ethnicity, gender, age, sexual orientation, disability, or any other dimension of diversity. Join us in creating an inclusive environment where everyone's voice is heard and valued.

Apply

Other jobs like this

Similar